Navigation Links
Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria
Date:2/24/2010

According to the Centers for Disease Control and Prevention, anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in hoofed mammals and can also infect humans. Symptoms of disease vary depending on how the disease is contracted, but usually occur within seven days after exposure. The serious forms of human anthrax are inhalation anthrax, cutaneous anthrax, and intestinal anthrax. Initial symptoms of inhalation anthrax infection may resemble a common cold. After several days, the symptoms may progress to severe breathing problems and shock. Inhalation anthrax is often fatal, even if treated by antibiotics.  Currently, antibiotics are the only drugs available for therapeutic or prophylactic use for inhalation anthrax, and post-exposure prophylaxis is the only FDA-approved indication for such products.  However, antibiotic therapy, while useful, is believed to be associated with a number of limitations, including: (1) lack of activity against the toxins produced by the B. anthracis bacteria, (2) need for long-term dosing to achieve full protection, complicated by side effects and non-compliance (3) lack of efficacy when administered late in the anthrax disease cycle, and (4) lack of effectiveness against multi-drug resistant or genetically engineered strains of anthrax.

About PharmAthene, Inc.

PharmAthene
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
2. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
3. Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
4. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
5. Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
6. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
7. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
8. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
9. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
10. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
11. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- LumiThera Inc., a developmental stage medical device company ... disorders and disease, announced today that they were ... Life Sciences Discovery Fund (LSDF) commercialization grant. LumiThera was ... grants worth $500,000 to provide for commercialization activities ... macular degeneration (AMD). LSDF executive ...
(Date:5/27/2015)... May 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/ljsxt8/asia_pacific ) ... X Ray Devices Market - Growth, Trends And Forecasts (2014 ... The Asia Pacific market for Portable ... from 2014 to 2020 X-Ray is a form ... in the body, especially bones. The need of point of ...
(Date:5/27/2015)... DUBLIN , May 26, 2015 Research ... the "Asia Pacific Fluoroscopy Market - Growth, Trends ... their offering. The Asia Pacific ... at a healthy CAGR from 2014 to 2020 ... to obtain real-time moving images of the interior of ...
Breaking Medicine Technology:LumiThera Receives LSDF Commercialization Grant Award 2Asia Pacific Portable X Ray Devices Market 2015 - Trends And Forecasts to 2019 2Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2
... Tenn. , Jan. 20 Cumberland Pharmaceuticals Inc. ( ... ) Injection, an intravenous form of ibuprofen, to Haitian relief effort. ... for the treatment of pain and reduction of fever in ... continue to deteriorate, Caldolor is expected to help those suffering from ...
... , , LOS ANGELES , ... that it has joined forces with New Jersey -based ... create the nation,s first IVF insurance program. The Assisted Reproduction ... financial solutions for the ever-rising costs of In Vitro Fertilization ...
Cached Medicine Technology:Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort 2Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort 3New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nation's First In Vitro Fertilization Insurance Program 2New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nation's First In Vitro Fertilization Insurance Program 3
(Date:5/27/2015)... Genius Monkey is pleased to announce ... technology, they have boosted sales for the Utah Honda ... level for seven Utah-based dealers. , Until recently, ... radio media. In 2014 the Utah Honda dealers changed ... Genius Monkey , shifted their marketing campaigns more towards ...
(Date:5/27/2015)... 2015 With InnerVoice Communication App ... the message is not only heard but seen -- by ... any motivating image. This award-winning and affordable app takes full ... Now, using InnerVoice Sender app in conjunction with ... a learner remotely for no additional cost. , InnerVoice ...
(Date:5/27/2015)... 27, 2015 With a prevalently high ... conducted during the "ACA - Controlling the Chaos" webinar ... are currently in the process of researching ACA ... confidently prepared for the reporting mandates. , According to ... webinar, those who are currently vetting ACA reporting solutions ...
(Date:5/27/2015)... SmarterSkin, http://www.smarterskindermatology.com , is taking skin ... that makes it easier for patients to find skin care ... Dr. Sejal Shah is a cosmetic dermatologist based in New ... the test. This revolutionary DNA test uses 16 genetic markers ... , 1. Firmness and elasticity , 2. Glycation ...
(Date:5/27/2015)... Portland, Oregon (PRWEB) May 27, 2015 ... treatments in North America, is offering free design advice ... the outside environment. , “Light pollution caused by ... can cause a restless night’s sleep, said Kim Rush, ... residents of numerous cities across North America with recently ...
Breaking Medicine News(10 mins):Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Decorview Helps Homeowners Combat Light Pollution 2
... CHICAGO, July 8 The Hispanic ... its 75 city tour, including the top 10,Hispanic cities, to ... The tour recently cruised through Chicago hosting free,events to encourage ... well,with nature,s wellness drink: milk. , ...
... ... Can Promote Prostate Health , ... Jacksonville, Fla. (Vocus) July 8, 2009 -- On June 30th, the ... effectiveness" research. Among the 100 different questions posed, high on the list was ...
... , WEDNESDAY, July 8 (HealthDay News) -- Though researchers aren,t ... longer, they hope a drug used to prevent rejection of ... , Middle-age mice that were given the drug rapamycin (Sirolimus) ... didn,t get the drug. , The findings, disclosed in a ...
... , WASHINGTON and EVANSTON, Ill., July 8 ... a data integration partnership facilitating integration of a ... SimCapture(R). SimCapture is an all-in-one solution for capturing, ... encounters. Mentice, manufacturer of the Mentice VIST(TM) endovascular ...
... patients rely on drugs to prevent graft rejection, ... The class of immunosuppressive drugs known as calcineurin ... patients, kidneys and lead to high blood pressure, ... can effectively replace calcineurin inhibitors in preventing graft ...
... SAN FRANCISCO, July 8 For the third ... one of the top medical groups in California as measured ... is the nation,s largest professional organization of physician groups practicing ... as being one of the best medical groups in California ...
Cached Medicine News:Health News:The Hispanic got milk? Campaign Visits Chicago from July 2 - July 10 2Health News:'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer 2Health News:'Easter Island' Drug Adds Years to Mice 2Health News:B-Line Medical(R) and Mentice, Inc. Announce Data Integration Partnership 2Health News:B-Line Medical(R) and Mentice, Inc. Announce Data Integration Partnership 3Health News:Post-transplant combo can replace toxic immune-suppressing drugs in monkeys 2
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 16x0.5ml tubes...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
... Sprint with 24-well x 0.2ml sub-ambient block ... tube thermistor) Heating rates: up to 3C/second; ... 4-99C; Excellent uniformity: better than 0.5C within ... use programming: directory program storage of up ...
... an inexpensive personal or mini thermal cycler, and ... with a small footprint, it can be easily ... desk. , The Gene Cycler thermal cycler meets ... access to a large laboratory thermal cycler, or ...
Medicine Products: